<?xml version='1.0' encoding='utf-8'?>
<document id="32248324"><sentence text="Effects of repeated oral doses of ketoconazole on a sequential ascending single oral dose of fedratinib in healthy subjects."><entity charOffset="34-46" id="DDI-PubMed.32248324.s1.e0" text="ketoconazole" /><entity charOffset="93-103" id="DDI-PubMed.32248324.s1.e1" text="fedratinib" /><pair ddi="false" e1="DDI-PubMed.32248324.s1.e0" e2="DDI-PubMed.32248324.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32248324.s1.e0" e2="DDI-PubMed.32248324.s1.e1" /></sentence><sentence text="Fedratinib is an orally administered Janus kinase 2-selective inhibitor that is indicated for the treatment of adult patients with intermediate-2 or high-risk myelofibrosis in the United States"><entity charOffset="0-10" id="DDI-PubMed.32248324.s2.e0" text="Fedratinib" /></sentence><sentence text=" Fedratinib is metabolized by multiple cytochrome P450s (CYPs) in vitro, with the predominant contribution from CYP3A4"><entity charOffset="1-11" id="DDI-PubMed.32248324.s3.e0" text="Fedratinib" /></sentence><sentence text=" The primary objective of this study was to evaluate the effects of 14-day repeated 200 mg twice daily (BID) oral doses of a strong CYP3A4 inhibitor, ketoconazole, on a sequential ascending single oral dose of fedratinib in healthy male subjects"><entity charOffset="150-162" id="DDI-PubMed.32248324.s4.e0" text="ketoconazole" /><entity charOffset="210-220" id="DDI-PubMed.32248324.s4.e1" text="fedratinib" /><pair ddi="false" e1="DDI-PubMed.32248324.s4.e0" e2="DDI-PubMed.32248324.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32248324.s4.e0" e2="DDI-PubMed.32248324.s4.e1" /></sentence><sentence text="" /><sentence text="An open-label, fixed-sequence, two-treatment cross-over study was conducted" /><sentence text=" Two cohorts of healthy adult males received two single doses of fedratinib (50 mg in Cohort 1 and 300 mg in Cohort 2) with one dose administered alone on Day 1 of Period 1 and the other dose coadministered with ketoconazole in the morning of Day 6 of Period 2"><entity charOffset="65-75" id="DDI-PubMed.32248324.s7.e0" text="fedratinib" /><entity charOffset="212-224" id="DDI-PubMed.32248324.s7.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.32248324.s7.e0" e2="DDI-PubMed.32248324.s7.e0" /><pair ddi="false" e1="DDI-PubMed.32248324.s7.e0" e2="DDI-PubMed.32248324.s7.e1" /></sentence><sentence text=" Subjects in both cohorts received 200-mg BID (Days 1-14) ketoconazole during Period 2"><entity charOffset="58-70" id="DDI-PubMed.32248324.s8.e0" text="ketoconazole" /></sentence><sentence text="" /><sentence text="Coadministration of repeated 200-mg BID oral doses of ketoconazole for 14 days increased fedratinib exposure by 3"><entity charOffset="54-66" id="DDI-PubMed.32248324.s10.e0" text="ketoconazole" /></sentence><sentence text="85- and 3" /><sentence text="06-fold for area under the plasma concentration-time curve from time zero to infinity following a single oral dose of fedratinib of 50 and 300 mg, respectively"><entity charOffset="118-128" id="DDI-PubMed.32248324.s12.e0" text="fedratinib" /></sentence><sentence text=" Oral administration of a single dose of 50 or 300 mg of fedratinib, administered alone or coadministered with steady-state ketoconazole, was safe and tolerable in the healthy male subjects"><entity charOffset="57-67" id="DDI-PubMed.32248324.s13.e0" text="fedratinib" /><entity charOffset="124-136" id="DDI-PubMed.32248324.s13.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.32248324.s13.e0" e2="DDI-PubMed.32248324.s13.e0" /><pair ddi="false" e1="DDI-PubMed.32248324.s13.e0" e2="DDI-PubMed.32248324.s13.e1" /></sentence><sentence text="" /><sentence text="These results serve as the basis for fedratinib dose reduction when fedratinib is coadministered with strong CYP3A4 inhibitors"><entity charOffset="37-47" id="DDI-PubMed.32248324.s15.e0" text="fedratinib" /><entity charOffset="68-78" id="DDI-PubMed.32248324.s15.e1" text="fedratinib" /><pair ddi="false" e1="DDI-PubMed.32248324.s15.e0" e2="DDI-PubMed.32248324.s15.e0" /><pair ddi="false" e1="DDI-PubMed.32248324.s15.e0" e2="DDI-PubMed.32248324.s15.e1" /></sentence><sentence text="" /></document>